Open Actively Recruiting

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

About

Brief Summary

This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation.

The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.

Study Type
Observational
Phase
Pilot/Feasibility

Eligibility

Gender
Male
Healthy Volunteers
No
Minimum Age
N/A
Maximum Age
N/A

Inclusion Criteria:

  • Patient has undergone or has elected to undergo hemi-gland cryoablation at UCLA
  • Low or intermediate risk prostate cancer (Gleason ≤ 7) or select high-risk patients (Gleason 8 prostate cancer).
  • Prostate volume of ≤ 70 cc
  • Ability to complete informed consent form

Exclusion criteria:

  • Medical contraindication to follow-up multi-parametric magnetic resonance imaging (mpMRI) or prostate biopsy
  • Patients unable to tolerate general or regional anesthesia.

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Study Stats
Protocol No.
17-001084
Category
Oncology
Urology
Location
  • UCLA Westwood
For Providers
NCT No.
NCT03503643
For detailed technical eligibility, visit ClinicalTrials.gov.